NeuCyte, Inc. and ReproCELL, Inc., a contract research organization (CRO), announced a new distribution agreement. This agreement will grant ReproCELL customers access to NeuCyte's pure and ready-to-use iPSC-derived glutamatergic and GABAergic induced neurons (iNs), supplied with astroglia, media and supplements. These components come in kit formats so the user can set up well-defined, highly functional in vitro co-culture systems for compound screening, disease modeling and neurotoxicity assessment. This partnership combines the stem cell science with the global customer network, adding new products and services to offer for drug discovery research and translational medicine.